TUCSON, Ariz., March 22, 2017 -- Since 1971, when the UK national registry for breast cancer was started, the incidence of breast cancer has continued to increase worldwide. Breast cancer screening, which started in the 1980s, increased detection but cannot account for the continuing increase in cases, write actuary Patrick Carroll and colleagues in the spring issue of the Journal of American Physicians and Surgeons. The lifetime risk of breast cancer for women is now around one in seven for malignant tumors and one in six if in-situ lesions are included, they write.
Certain risk factors, they note, including childlessness, are widely acknowledged, as are protective factors such as a young age at the birth of the first child, further full-term pregnancies, and longer breastfeeding.
But most health authorities have been unwilling to acknowledge the long-term risk of hormonal contraceptives, although it is similar to that of hormone-replacement therapy, which doctors are now reluctant to prescribe, Carroll et al. observe. Likewise, epidemiologists are not warning women of the additional risk of induced abortion, and British medical journals do not publish articles showing the link. Authors note that under the 1967 Abortion Act two physicians must approve an abortion, and if an abortion-breast cancer link were accepted, many more professional liability cases would likely be brought.
Using a linear regression model incorporating cohort rates of fertility and induced abortions, Carroll et al. were able to forecast future incidence of breast cancer accurately.
Hormonal and reproductive risk factors also help to explain the “social gradient,” the authors write. Women in higher socioeconomic groups have a higher incidence of breast cancer. Upper class and upwardly mobile women may be more likely to have nulliparous abortions, later childbirth, and fewer children, authors suggest.
Accurate forecasting of future case numbers is important in planning treatment facilities, the authors state.
The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS), a national organization representing physicians in all specialties since 1943.
Contact: Patrick Carroll, [email protected], or Jane M. Orient, M.D., (520) 323-3110, [email protected]


Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share
Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
U.S. Raises Alarm Over Chinese AI Firms’ Alleged IP Theft Through Model Distillation
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases
DeepSeek Launches V4 AI Models with Enhanced Reasoning and 1M Token Context Window
Kakaku.com Stock Surges on EQT Takeover Interest Amid Rising Japan Deal Activity
Tesla Earnings Beat Expectations as EV Growth Holds Amid Robotics and AI Shift
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure
SK Hynix to Invest $13 Billion in AI Chip Packaging Facility 



